New treatments for ocular hypertension

Autonomic Neuroscience: Basic and Clinical

Volumn 147, Issue 1-2, 2009, Pages 14-19

  Mediero, Aránzazu ^a   Alarma Estrany, Pilar ^a   Pintor, Jesús ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Glaucoma; Melatonin; Nucleotides; Ocular hypertension; RNAi; siRNA

Indexed keywords

ADRENERGIC RECEPTOR BLOCKING AGENT; ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLINERGIC RECEPTOR STIMULATING AGENT; LATANOPROST; MELATONIN; NUCLEOTIDE; SMALL INTERFERING RNA; TIMOFTOL; TIMOLOL; UNCLASSIFIED DRUG;

ARTICLE; DRUG INDUSTRY; DRUG TARGETING; GLAUCOMA; HUMAN; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; NERVOUS SYSTEM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; UNSPECIFIED SIDE EFFECT;

ADRENERGIC AGENTS; ANIMALS; EYE; GLAUCOMA; HUMANS; MELATONIN; NEUROPHARMACOLOGY; NUCLEOTIDES; OCULAR HYPERTENSION; PARASYMPATHOMIMETICS; RNA INTERFERENCE; RNA, SMALL INTERFERING;

EID: 64649099532     PISSN: 15660702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autneu.2008.12.009     Document Type: Article

References (66)

1. Abbracchio M.P., Burnstock G., Boeynaems J.M., Barnard E.A., Boyer J.L., Kennedy C., Knight G.E., Fumagalli M., Gachet C., and Jacobson. International Union of Pharmacology LVIII: update on the P2Y G proteincoupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy. Pharmacol. Rev. 58 (2006) 281-341
2. Alarma-Estrany P., and Pintor J. Melatonin receptors in the eye: location, second messengers and role in ocular physiology. Pharmacol. Ther. 113 (2007) 507-522
3. Alarma-Estrany P., Crooke A., Peral A., and Pintor J. Requirement of intact sympathetic transmission for the ocular hypotensive effects of melatonin and 5-MCA-NAT. Auton. Neurosci. 137 (2007) 63-66
4. 2-melatonin receptors in normotensive rabbits. J Pineal Res. 45 (2008) 468-475
5. Brusini P., and Johnson C.A. Staging functional damage in glaucoma: review of different classification methods. Surv. Ophthalmol. 52 (2007) 156-179
6. Bumcrot D., Manoharan M., Koteliansky V., and Sah D.W. RNAi therapeutics: a potential new class of pharmaceutical drugs. Nat. Chem. Biol. 2 (2006) 711-719
7. Campochiaro P.A. Potential applications for RNAi to probe pathogenesis and develop new treatments for ocular disorders. Gene Ther. 13 (2006) 559-562
8. Chiquet C., Claustrat B., Thuret G., Brun J., Cooper H.M., and Denis P. Melatonin concentrations in aqueous humor of glaucoma patients. Am. J. Ophthalmol. 142 (2006) 325-327 e1
9. Coca-Prados M., and Escribano J. New perspectives in aqueous humor secretion and in glaucoma: the ciliary body as a multifunctional neuroendocrine gland. Prog. Retin. Eye Res. 26 (2007) 239-262
10. Elbashir S.M., Lendeckel W., and Tuschl T. RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes Dev. 15 (2001) 188-200
11. Ericson L.A. Twenty-four hourly variations of the aqueous flow; examinations with perilimbal suction cup. Acta Ophthalmol. 37 Suppl 50 (1958) 1-95
12. Farahbakhsh N.A., and Cilluffo M.C. P2 purinergic receptor-coupled signaling in the rabbit ciliary body epithelium. Invest. Ophthalmol. Vis. Sci. 43 (2002) 2317-2325
13. Fire A., Xu S., Montgomery M.K., Kostas S.A., Driver S.E., and Mello C.C. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391 (1998) 806-811
14. Gever J.R., Cockayne D.A., Dillon M.P., Burnstock G., and Ford A.P.D.W. Pharmacology of P2X channels. Pflugers Arch. Eur. J. Physiol. 452 (2006) 513-537
15. Giraldez L., Diaz-Hernandez M., Gomez-Villafuertes R., Pintor J., Castro E., and Miras-Portugal M.T. Adenosine triphosphate and diadenosine pentaphosphate induce [Ca(2+)](i) increase in rat basal ganglia aminergic terminals. J. Neurosci. Res. 64 (2001) 174-182
16. Jimenez A., Sesto A., Pintor J., Mediero A., and Peral A. Na+/K+ ATPase: a new target for treating ocular hypertension by RNAi. Invest. Ophthalmol. Vis. Sci. (2007) Abstract 4809/B100
17. Kennerdell J.R., and Carthew R.W. Use of dsRNA-mediated genetic interference to demonstrate that frizzled and frizzled 2 act in the wingless pathway. Cell 95 (1998) 1017-1026
18. Koskela T., and Brubaker R.F. The nocturnal suppression of aqueous humor flow in humans is not blocked by bright light. Invest. Ophthalmol. Vis. Sci. 32 (1991) 2504-2506
19. Lee D.A., and Higginbotham E.J. Glaucoma and its treatment: a review. Am. J. Health-Syst. Pharm. 62 (2005) 691-699
20. Lincoln G.A., Almeida O.F., and Arendt J. Role of melatonin and circadian rhythms in seasonal reproduction in rams. J. Reprod. Fertil. Suppl. 30 (1981) 23-31
21. Liu J.H., and Dacus A.C. Endogenous hormonal changes and circadian elevation of intraocular pressure. Invest. Ophthalmol. Vis. Sci. 32 (1991) 496-500
22. Lohmann J.U., Endl I., and Bosch T.C. Silencing of developmental genes in Hydra. Dev. Biol. 214 (1999) 211-214
23. Martin X.D., Malina H.Z., Brennan M.C., Hendrickson P.H., and Lichter P.R. The ciliary body-the third organ found to synthesize indoleamines in humans. Eur. J. Ophthalmol. 2 (1992) 67-72
24. Mayo J.C., Sainz R.M., Uria H., Antolin I., Esteban M.M., and Rodriguez C. Melatonin prevents apoptosis induced by 6-hydroxydopamine in neuronal cells:implications for Parkinson's disease. J. Pineal Res. 24 (1998) 179-192
25. Mitchell C.H., Carre D.A., McGlinn A.M., Stone R.A., and Civan M.M. A release mechanism for stored ATP in ocular ciliary epithelial cells. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 7174-7178
26. Nakamura H., Siddiqui S.S., Shen X., Malik A.B., Pulido J.S., Kumar N.M., and Yue B.Y. RNA interference targeting transforming growth factor-beta type II receptor suppresses ocular inflammation and fibrosis. Mol. Vis. 10 (2004) 703-711
27. Ngô H., Tschudi C., Gull K., and Ullu E. Double-stranded RNA induces mRNA degradation in Trypanosoma brucei. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 14687-14692
28. 3 as the quinone reductase 2. J. Biol. Chem. 275 (2000) 31311-31317
29. Nucci C., Tartaglione R., Cerulli A., Mancino R., SpanÚ A., Cavaliere F., Rombol‡ L., Bagetta G., Corasaniti M.T., Morrone L.A., et al. Retinal damage caused by high intraocular pressure-induced transient ischemia is prevented by coenzyme Q10 in rat. International Review of Neurobiology vol. 82 (2007), Academic Press 397-406
30. Nykänen A., Haley B., and Zamore P.D. ATP requirements and small interfering RNA structure in the RNA interference pathway. Cell 107 (2001) 309-321
31. Oelgeschlager M., Larrain J., Geissert D., and DeRobertis E.M. The evolutionarily conserved BMP-binding protein twisted gastrulation promotes BMP signalling. Nature 405 (2007) 757-763
32. Osborne N.N., and Chidlow G. The presence of functional melatonin receptors in the iris-ciliary processes of the rabbit eye. Exp. Eye Res. 59 (1994) 3-9
33. Osborne N.N., Ugarte M., Chao M., Chidlow G., Bae J.H., Wood J.P., and Nash M.S. Neuroprotection in relation to retinal ischemia and relevance to glaucoma. Surv. Ophthalmol. 43 1 (1999) S102-S128
34. Pappolla M.A., Chyan Y.J., Poeggeler B., Bozner P., Ghiso J., LeDoux S.P., et al. Alzheimer beta protein mediated oxidative damage of mitochondrial DNA: prevention by melatonin. J. Pineal Res. 27 (1999) 226-229
35. Peral A., Loma P., Mediero A., Sesto A., Pintor J., and Jimenez A.I. Effect of several siRNA in the treatment of ocular hypertension and glaucoma. Invest. Ophthalmol. Vis. Sci. 48 (2007) 4808
36. Pereira M.F., Hernandez M.D., Pintor J., Miras-Portugal M.T., Cunha R.A., and Ribeiro J.A. Diadenosine polyphosphates facilitate the evoked release of acetylcholine from rat hippocampal nerve terminals. Brain Res. 879 (2000) 50-54
37. Pintor J. Nucleotides as a new alternative for the treatment of ocular hypertension. Arch. Soc. Esp. Oftalmol. 78 (2003) 295-296
38. Pintor J., and Peral A. Therapeutic potential of nucleotidesin the eye. Drug Dev. Res. 52 (2001) 190-195
39. Pintor J., Diaz-Rey M.A., Torres M., and Miras-Portugal M.T. Presence of diadenosine polyphosphates-Ap4A and Ap5A-in rat brain synaptic terminals. Ca2+ dependent release evoked by 4-aminopyridine and veratridine. Neurosci. Lett. 136 (1992) 141-144
40. Pintor J., Martin L., Pelaez T., Hoyle C.H., and Peral A. Involvement of melatonin MT(3) receptors in the regulation of intraocular pressure in rabbits. Eur. J. Pharmacol. 416 (2001) 251-254
41. Pintor J., Peral A., Pelaez T., Carracedo G., Bautista A., and Hoyle C.H.V. Nucleotides and dinucleotides in ocular physiology: new possibilities of nucleotides as therapeutic agents in the eye. Drug Dev. Res. 59 1 (2003) 136-145
42. Pintor J., Peral A., Pelaez T., Martin S., and Hoyle C.H.V. Presence of diadenosine polyphosphates in the aqueous humor: their effect on intraocular pressure. J. Pharmacol. Exp. Ther. 304 (2003) 342-348
43. 3 receptor. Br. J. Pharmacol. 138 (2003) 831-836
44. Pintor J.J., Mediero A., Jimenez A., Sesto A., Gonzalez de Buitrago G., and Peral A. siRNA in the treatment of ocular hypertension targeting alpha and beta adrenoceptors. Invest. Ophthalmol. Vis. Sci. (2006) Abstract 403/B61
45. Pruss G., Ge X., shi X.M., Carrnington J.C., and Vance V.B. Plant viral synergism: the potyviral genome encodes a broad-range pathogenicity enhancer that transactivates replication of heterologous viruses. Plant Cell 9 (1997) 1749-1759
46. Reiss G.R., Lee D.A., Topper J.E., and Brubaker R.F. Aqueous humor flow during sleep. Invest. Ophthalmol. Vis. Sci. 25 (1984) 776-778
47. Reich S.J., Fosnot J., Kuroki A., Tang W., Yang X., Maguire A.M., Bennett J., and Tolentino M.J. Small interfering RNA (siRNA) targeting VEGF effectively inhibits ocular neovascularization in a mouse model. Mol. Vis. 9 (2003) 210-216
48. Reiter R.J., Tan D.X., Cabrera J., D'Arpa D., Sainz R.M., Mayo J.C., et al. The oxidant/antioxidant network: role of melatonin. Biol. Signals Recept. 8 (1999) 56-63
49. Reppert S.M., Weaver D.R., and Ebisawa T. Cloning and characterization of a mammalian melatonin receptor that mediatesre productive and circadian responses. Neuron 13 (1994) 1177-1185
50. Roca A.L., Godson C., Weaver D.R., and Reppert S.M. Structure, characterization, and expression of the gene encoding the mouse Mel1a melatonin receptor. Endocrinology 137 (1996) 3469-3477
51. Samples J.R., Krause G., and Lewy A.J. Effect of melatonin on intraocular pressure. Curr. Eye Res. 7 (1988) 649-653
52. Schwartz G.F., Reardon G., and Mozaffari E. Persistency with latanoprost or timolol in primary open-angle glaucoma suspects. Am. J. Ophthalmol. 137 1 Suppl (2004) S13-S16
53. 3 receptor agonist, on intraocular pressure in glaucomatous monkey eyes. J. Glaucoma 13 (2004) 385-388
54. Shen J., Samul R., Silva R.L., Akiyama H., Liu H., Saishin Y., Hackett S.F., Zinnen S., Kossen K., Fosnaugh K., Vargeese C., Gomez A., Bouhana K., Aitchison R., Pavco P., and Campochiaro P.A. Suppression of ocular neovascularization with siRNA targeting VEGF receptor 1. Gene Ther. 13 (2006) 225-234
55. Shuey D.J., McCallus D.E., and Giordano T. RNAi: gene-silencing in therapeutic intervention. Drug Discov. Today 7 (2002) 1040-1046
56. Soto D., Pintor J., Peral A., Gual A., and Gasull X. Effects of dinucleoside polyphosphates on trabecular meshwork cells and aqueous humor outflow facility. J. Pharmacol. Exp. Ther. 314 (2005) 1042-1051
57. To C.H., Kong C.W., Chan C.Y., Shahidullah M., and Do C.W. The mechanism of aqueous humour formation. Clin. Exp. Optom. 85 (2002) 335-349
58. Tsai J.C., and Kanner E.M. Current and emerging medical therapies for glaucoma. Expert Opin. Emerg. Drugs 10 (2005) 109-118
59. Van der Krol A.R., Mur L.A., de Lange P., Mol J.N., and Stuitje A.R. Inhibition of flower pigmentation by antisense CHS genes: promoter and minimal sequence requirements for the antisense effect. Plant Mol. Biol. 14 (1990) 457-466
60. Vaughan G.M., and Reiter R.J. Pineal dependence of the Syrian hamster's nocturnal serum melatonin surge. J. Pineal Res. 3 (1986) 9-14
61. Wargelius A., Ellingsen S., and Fjose A. Double-stranded RNA induces specific developmental defects in zebrafish embryos. Biochem. Biophys. Res. Commun. 263 (1999) 156-161
62. Wianny F., and Zernicka-Goetz M. Specific interference with gene function by double-stranded RNA in early mouse development. Nat. Cell Biol. 2 (2000) 70-75
63. Wiechmann A.F., and Wirsig-Wiechmann C.R. Melatonin receptor mRNA and protein expression in Xenopus laevis nonpigmented ciliary epithelial cells. Exp. Eye Res. 73 (2001) 617-623
64. Yu H.S., Yee R.W., Howes K.A., and Reiter R.J. Diurnal rhythms of immunoreactive melatonin in the aqueous humor and serum of male pigmented rabbits. Neurosci. Lett. 116 (1990) 309-314
65. Zhang A., Jian G.Li., Reigada D., Laties A.M., and Mitchell C.H. Acute increase of intraocular pressure releases ATP into the anterior chamber. Exp. Eye Res. 85 5 (2007) 637-643
66. Zimmermann H. Signalling via ATP in the nervous system. Trends Neurosci. 17 (1994) 420-426